Skip to main content

Medications for Hyperphosphatemia of Renal Failure

The medications listed below are related to or used in the treatment of this condition.

Filter
Drug name Rating Reviews Activity ? Rx/OTC Pregnancy CSA Alcohol
Auryxia 5.7 6 reviews for Auryxia to treat Hyperphosphatemia of Renal Failure
Rx B N
Generic name:
ferric citrate systemic
Drug class:
phosphate binders
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Carafate Rate Add review
Rx B N
Generic name:
sucralfate systemic
Drug class:
miscellaneous GI agents
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
ferric citrate 5.7 6 reviews for ferric citrate to treat Hyperphosphatemia of Renal Failure
Rx B N
Generic name:
ferric citrate systemic
Brand name:
Auryxia
Drug class:
phosphate binders
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
Fosrenol 7.2 5 reviews for Fosrenol to treat Hyperphosphatemia of Renal Failure
Rx C N
Generic name:
lanthanum carbonate systemic
Drug class:
phosphate binders
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
lanthanum carbonate 7.1 7 reviews for lanthanum carbonate to treat Hyperphosphatemia of Renal Failure
Rx C N
Generic name:
lanthanum carbonate systemic
Brand name:
Fosrenol
Drug class:
phosphate binders
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
magnesium carbonate Rate Add review
Rx/OTC N N
Generic name:
magnesium carbonate systemic
Drug class:
minerals and electrolytes
For consumers:
dosage, interactions, side effects
Renagel 7.0 1 review for Renagel to treat Hyperphosphatemia of Renal Failure
Rx C N
Generic name:
sevelamer systemic
Drug class:
phosphate binders
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Renvela 5.0 7 reviews for Renvela to treat Hyperphosphatemia of Renal Failure
Rx C N
Generic name:
sevelamer systemic
Drug class:
phosphate binders
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
sevelamer 5.1 16 reviews for sevelamer to treat Hyperphosphatemia of Renal Failure
Rx C N
Generic name:
sevelamer systemic
Brand names:
Renvela, Renagel
Drug class:
phosphate binders
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
sucralfate Rate Add review
Rx B N
Generic name:
sucralfate systemic
Brand name:
Carafate
Drug class:
miscellaneous GI agents
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
sucroferric oxyhydroxide 5.4 11 reviews for sucroferric oxyhydroxide to treat Hyperphosphatemia of Renal Failure
Rx B N
Generic name:
sucroferric oxyhydroxide systemic
Brand name:
Velphoro
Drug class:
phosphate binders
For consumers:
interactions, side effects
For professionals:
AHFS DI Monograph
tenapanor Rate Add review
Rx N
Generic name:
tenapanor systemic
Brand name:
Xphozah
Drug class:
NHE3 inhibitors
For consumers:
dosage, side effects
For professionals:
AHFS DI Monograph
Velphoro 5.4 11 reviews for Velphoro to treat Hyperphosphatemia of Renal Failure
Rx B N
Generic name:
sucroferric oxyhydroxide systemic
Drug class:
phosphate binders
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Xphozah Rate Add review
Rx N
Generic name:
tenapanor systemic
Drug class:
NHE3 inhibitors
For consumers:
dosage, side effects
For professionals:
Prescribing Information

Legend

Rating For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective).
Activity Activity is based on recent site visitor activity relative to other medications in the list.
Rx Prescription only.
OTC Over-the-counter.
Rx/OTC Prescription or Over-the-counter.
Off-label This medication may not be approved by the FDA for the treatment of this condition.
EUA An Emergency Use Authorization (EUA) allows the FDA to authorize unapproved medical products or unapproved uses of approved medical products to be used in a declared public health emergency when there are no adequate, approved, and available alternatives.
Expanded Access Expanded Access is a potential pathway for a patient with a serious or immediately life-threatening disease or condition to gain access to an investigational medical product (drug, biologic, or medical device) for treatment outside of clinical trials when no comparable or satisfactory alternative therapy options are available.
Pregnancy Category
A Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).
B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
C Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
D There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
X Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits.
N FDA has not classified the drug.
Controlled Substances Act (CSA) Schedule
M The drug has multiple schedules. The schedule may depend on the exact dosage form or strength of the medication.
U CSA Schedule is unknown.
N Is not subject to the Controlled Substances Act.
1 Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision.
2 Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence.
3 Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence.
4 Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3.
5 Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4.
Alcohol
X Interacts with Alcohol.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.